-
ICD-10-CM Codes
›
-
E00-E89
›
-
E70-E88
›
-
E85-
›
-
2023 ICD-10-CM Diagnosis Code E85.0
2023 ICD-10-CM Diagnosis Code E85.0
Non-neuropathic heredofamilial amyloidosis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- E85.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM E85.0 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E85.0 - other international versions of ICD-10 E85.0 may differ.
Applicable To- Hereditary amyloid nephropathy
Code AlsoCode Also Help
A code also note instructs that 2 codes may be required to fully describe a condition but the sequencing of the two codes is discretionary, depending on the severity of the conditions and the reason for the encounter.
Type 2 ExcludesType 2 Excludes Help
A type 2 excludes note represents "not included here". A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code (E85.0) and the excluded code together.
The following code(s) above
E85.0 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
E85.0:
- E00-E89
2023 ICD-10-CM Range E00-E89
Endocrine, nutritional and metabolic diseasesNote- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Type 1 Excludes- transitory endocrine and metabolic disorders specific to newborn (P70-P74)
- E70-E88
2023 ICD-10-CM Range E70-E88
Metabolic disordersType 1 Excludes- androgen insensitivity syndrome (E34.5-)
- congenital adrenal hyperplasia (E25.0)
- hemolytic anemias attributable to enzyme disorders (D55.-)
- Marfan's syndrome (Q87.4)
- 5-alpha-reductase deficiency (E29.1)
Type 2 Excludes- Ehlers-Danlos syndromes (Q79.6-)
- E85
ICD-10-CM Diagnosis Code E85
Amyloidosis
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
- Familial mediterranean fever
- Familial non-neuropathic amyloidosis
- Nonneuropathic heredofamilial amyloidosis
Clinical Information
- A group of hereditary autoinflammation diseases, characterized by recurrent fever, abdominal pain, headache, rash, pleurisy; and arthritis. Orchitis; benign meningitis; and amyloidosis may also occur. Homozygous or compound heterozygous mutations in marenostrin gene result in autosomal recessive transmission; simple heterozygous, autosomal dominant form of the disease.
- A usually autosomal recessive inherited inflammatory disorder caused by mutations in the mefv gene. It is characterized by recurrent painful inflammatory attacks in the abdomen, joints, and chest. The inflammatory attacks are associated with fever.
ICD-10-CM E85.0 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
- 545 Connective tissue disorders with mcc
- 546 Connective tissue disorders with cc
- 547 Connective tissue disorders without cc/mcc
Convert E85.0 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
Code annotations containing back-references to E85.0:
- Amyloidosis (generalized) (primary) E85.9
ICD-10-CM Diagnosis Code E85.9
Amyloidosis, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- non-neuropathic heredofamilial E85.0
- Myopathy G72.9
ICD-10-CM Diagnosis Code G72.9
Myopathy, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- Nephropathy N28.9 - see also Nephritis
ICD-10-CM Diagnosis Code N28.9
Disorder of kidney and ureter, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Nephropathy NOS
- Renal disease (acute) NOS
- Renal insufficiency (acute)
Type 1 Excludes- chronic renal insufficiency (N18.9)
- unspecified nephritic syndrome (N05.-)
- amyloid, hereditary E85.0
- Peritonitis (adhesive) (bacterial) (fibrinous) (hemorrhagic) (idiopathic) (localized) (perforative) (primary) (with adhesions) (with effusion) K65.9
ICD-10-CM Diagnosis Code K65.9
Peritonitis, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
Applicable To- Bacterial peritonitis NOS
- Polyserositis
ICD-10-CM Codes Adjacent To E85.0
E83.89 Other disorders of mineral metabolism
E83.9 Disorder of mineral metabolism, unspecified
E84.0 Cystic fibrosis with pulmonary manifestations
E84.1 Cystic fibrosis with intestinal manifestations
E84.11 Meconium ileus in cystic fibrosis
E84.19 Cystic fibrosis with other intestinal manifestations
E84.8 Cystic fibrosis with other manifestations
E84.9 Cystic fibrosis, unspecified
E85.0
Non-neuropathic heredofamilial amyloidosis
E85.1 Neuropathic heredofamilial amyloidosis
E85.2 Heredofamilial amyloidosis, unspecified
E85.3 Secondary systemic amyloidosis
E85.4 Organ-limited amyloidosis
E85.81 Light chain (AL) amyloidosis
E85.82 Wild-type transthyretin-related (ATTR) amyloidosis
E85.9 Amyloidosis, unspecified
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
